CYP3A4 blocking peptide product blog
Tags: Cytochrome P450 3A4; CYP3A4; Blocking Peptide; CYP3A4 blocking peptide;
The CYP3A4 cyp3a4 (Catalog #MBS822762) is a Blocking Peptide produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The Cytochrome P450 3A4 Blocking Peptide reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s Cytochrome P450 3A4 can be used in a range of immunoassay formats including, but not limited to, Blocking (BL).Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 degree C for overnight or at room temperature for 2 hours. Researchers should empirically determine the suitability of the CYP3A4 cyp3a4 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CYP3A4 cyp3a4 product has the following accession number(s) (GI #322302351) (NCBI Accession #NP_001189784.1) (Uniprot Accession #P08684). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
The peptide is used to block Anti-Cytochrome P450 3A4 Antibody reactivity.
Quality Control: The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry. Adrenal Gland, Brain, Connective Tissue, Intestine, Kidney, Liver, Mammary Gland, Mouth, Muscle, Stomach tissues are correlated with this protein. The following patways have been known to be associated with this gene. Breast Neoplasms, Cardiovascular Diseases, Drug-Related Side Effects and Adverse Reactions, Heart Diseases, Hypertension, Kidney Diseases, Liver Diseases, Nausea, Nervous System Diseases, Pain are some of the diseases may be linked to Cytochrome P450 3A4 Blocking Peptide. CYP3A4 also interacts with the following gene(s): GSTA1, GSTA2, UGT1A1, UGT1A10, UGT1A4, UGT1A7, UGT1A8, UGT1A9, UGT2B7.